$GCTKJul 17, 2026, 12:05 PMAI processed
GCTK secures bridge financing from E.F. Hutton post-merger
AI Summary
Glucotrack (GCTK) and operating business Lōkahi Therapeutics completed a bridge financing with E.F. Hutton & Co. acting as exclusive financial advisor and placement agent to support integration after their July 14 business combination. The funding is intended to provide short-term liquidity for the combined platform and to advance Lōkahi’s ai2 programs and the ai2 Futures Lab, while the company continues to evaluate additional financing opportunities (no amount or terms disclosed).
Positives
- Completed bridge financing to support post-merger integration and strategic initiatives
- Financing is earmarked to support Lōkahi’s ai² development programs, including the ai² Futures Lab
Negatives
- Company did not disclose the amount or economic terms of the bridge financing
- Funding described as bridge financing, implying likely need for additional, longer-term capital
- Merger integration and future capital raises remain outstanding execution risks